Dabigatran
- Level
- Commodity
- Parent
- 51131600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51131631This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I0VM4M70GC. European Medicines Agency schedules Dabigatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25417. Dabigatran generally arises in the molecular formula C25H25N7O3. The term DABIGATRAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46.) Most nations schedule dabigatran under HS 29333999 and SITC 51574. As of Q4 2014, DABIGATRAN remains the US FDA Preferred Term for this commodity. Dabigatran bears US NLM identifiers UMLS ID C2348066 and NCI Concept Code C73224. SMILES: O=C(N(CCC(=O)O)C1NCCCC1)C1CC2NC(N(C2CC1)C)CNC1CCC(CC1)C(=N)N.
Same parent
Under 51131600 · 61Activities that produce or sell this
KBLI · 8Inherited from family 51130000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.